Content about Apotex

February 21, 2013

GPhA appoints board of directors for 2013

The Generic Pharmaceutical Association re-elected its chairman from last year and appointed a new board of directors for 2013 whose members run from A to Z — as in Amneal to Zydus.

January 15, 2013

Reports: Otsuka can block Apotex's generic version of Abilify

Drug maker Otsuka Pharmaceuticals can keep generic versions of its schizophrenia drug off the market, according to published reports.

December 18, 2012

FDA approves generic HIV drug

The Food and Drug Administration has approved two generic versions of a drug to treat HIV, according to agency records.

October 9, 2012

Ranbaxy launches authorized generic autoimmune drug

Ranbaxy Labs has launched an authorized generic drug for treating dry mouth associated with an autoimmune disorder, the company said Tuesday.

May 8, 2012

Reports: Court upholds Abilify patent

A generic version of a schizophrenia drug made by Otsuka Holdings and Bristol-Myers Squibb can't be launched until April 2015, according to published reports.

March 19, 2012

FDA approves generic versions of osteoporosis drug

The Food and Drug Administration has approved the first generic version of a drug for treating and preventing osteoporosis in women after menopause, the agency said Monday.

February 28, 2012

Report: Court OKs agreement between GSK, Apotex over generic Paxil CR

GlaxoSmithKline can sell an authorized generic of its antidepressant drug to Toronto-based drug maker Apotex, a U.S. judge ruled.

October 18, 2010

Mylan denied preliminary injunction against GSK, Apotex

A U.S. District Court denied a motion for a preliminary injunction filed by Mylan to...

September 21, 2010

Court blocks Apotex's generic Paxil CR

A U.S. District Court has blocked Canadian generic drug maker Apotex from selling generic versions...